Literature DB >> 25087173

Multimodal management of muscle-invasive bladder cancer.

Jong Chul Park, Deborah E Citrin, Piyush K Agarwal, Andrea B Apolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25087173      PMCID： PMC4190161          DOI： 10.1016/j.currproblcancer.2014.06.001

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN： 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  182 in total

1.  Complications after radical cystectomy: analysis of population-based data.

Authors:  Badrinath R Konety; Veerasathpurush Allareddy; Harry Herr
Journal:  Urology       Date:  2006-06-27       Impact factor: 2.649

2.  Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.

Authors:  Achim Fleischmann; Diana Rotzer; Roland Seiler; Urs E Studer; George N Thalmann
Journal:  Eur Urol       Date:  2011-05-25       Impact factor: 20.096

3.  Long-term outcome related to epidermal growth factor receptor status in bladder cancer.

Authors:  K Mellon; C Wright; P Kelly; C H Horne; D E Neal
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

4.  [Thromboembolic venous disease as a first sign of neoplastic disease--a case report].

Authors:  Anna Drosik; Barbara Trzepióra; Jerzy Kozielski
Journal:  Wiad Lek       Date:  2012

5.  The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response.

Authors:  D S Kaufman; K A Winter; W U Shipley; N M Heney; M P Chetner; L Souhami; R A Zlotecki; W T Sause; L D True
Journal:  Oncologist       Date:  2000

6.  Clinical experience with radiotherapy alone and radiochemotherapy with platin based regimens in organ-sparing treatment of invasive bladder cancer.

Authors:  Hanan Sh Gamal El-Deen; Hala F Elshazly; Esam A Abo Zeina
Journal:  J Egypt Natl Canc Inst       Date:  2009-03

7.  Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma.

Authors:  Daniel Herchenhorn; Rodrigo Dienstmann; Fabio A Peixoto; Franz S de Campos; Valdelice O Santos; Denise M Moreira; Hedilene Cardoso; Isabele A Small; Carlos G Ferreira
Journal:  Int Braz J Urol       Date:  2007 Sep-Oct       Impact factor: 1.541

8.  Brachytherapy versus cystectomy in solitary bladder cancer: a case control, multicentre, East-Netherlands study.

Authors:  Elzbieta van der Steen-Banasik; Martine Ploeg; Johannes A Witjes; Farida S van Rey; Jan G Idema; Robert P Heijbroek; Herbert F Karthaus; Janny G Reinders; A Viddeleer; Andries G Visser
Journal:  Radiother Oncol       Date:  2009-05-18       Impact factor: 6.280

9.  Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer.

Authors:  Michael P Porter; Matthew C Kerrigan; Bonnie M K Donato; Scott D Ramsey
Journal:  Urol Oncol       Date:  2009-05-17       Impact factor: 3.498

10.  Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model.

Authors:  Guru Sonpavde; Weiguo Jian; Hao Liu; Meng-Fen Wu; Steven S Shen; Seth P Lerner
Journal:  Urol Oncol       Date:  2008-06-04       Impact factor: 3.498
View more
  26 in total

1.  Musashi-2 promotes migration and invasion in bladder cancer via activation of the JAK2/STAT3 pathway.

Authors:  Chenlu Yang; Weijing Zhang; Longwang Wang; Gallina Kazobinka; Xiaomin Han; Bin Li; Teng Hou
Journal:  Lab Invest       Date:  2016-06-20       Impact factor: 5.662

2.  Targeting IL-5Rα with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer.

Authors:  Michel Paquette; Luis-Guillermo Vilera-Perez; Simon Beaudoin; Nadia Ekindi-Ndongo; Pierre-Luc Boudreaut; Marc-Andre Bonin; Marie-Claude Battista; M'hamed Bentourkia; Angel F Lopez; Roger Lecomte; Eric Marsault; Brigitte Guérin; Robert Sabbagh; Jeffrey V Leyton
Journal:  Oncoimmunology       Date:  2017-05-19       Impact factor: 8.110

3.  Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.

Authors:  Fabrícia Dietrich; Fabrício Figueiró; Eduardo Cremonese Filippi-Chiela; Angélica Regina Cappellari; Liliana Rockenbach; Alain Tremblay; Patrícia Boni de Paula; Rafael Roesler; Aroldo Braga Filho; Jean Sévigny; Fernanda Bueno Morrone; Ana Maria Oliveira Battastini
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-05       Impact factor: 4.553

4.  Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer.

Authors:  Venkatrao Vantaku; Jianrong Dong; Chandrashekar R Ambati; Dimuthu Perera; Sri Ramya Donepudi; Chandra Sekhar Amara; Vasanta Putluri; Shiva Shankar Ravi; Matthew J Robertson; Danthasinghe Waduge Badrajee Piyarathna; Mariana Villanueva; Friedrich-Carl von Rundstedt; Balasubramanyam Karanam; Leomar Y Ballester; Martha K Terris; Roni J Bollag; Seth P Lerner; Andrea B Apolo; Hugo Villanueva; MinJae Lee; Andrew G Sikora; Yair Lotan; Arun Sreekumar; Cristian Coarfa; Nagireddy Putluri
Journal:  Clin Cancer Res       Date:  2019-03-07       Impact factor: 12.531

5.  High P2X6 receptor expression in human bladder cancer predicts good survival prognosis.

Authors:  Fabrícia Dietrich; Angélica Regina Cappellari; Eduardo Cremonese Filippi-Chiela; Patrícia Boni de Paula; Julia Brandt de Souza; Stefano Walter Agatti; Roberta Andrejew; Rafael Roesler; Fernanda Bueno Morrone; Ana Maria Oliveira Battastini
Journal:  Mol Cell Biochem       Date:  2022-04-16       Impact factor: 3.396

6.  Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-ĸB-modulated Survival and Invasion Potential in Bladder Cancer.

Authors:  Yu-Chang Liu; Kuang-Hsuan Lin; Jung-Hung Hsieh; Jing-Gung Chung; Zhao-Lin Tan; Fei-Ting Hsu; Chih-Hung Chiang
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

Review 7.  MicroRNAs as biomarkers associated with bladder cancer.

Authors:  Amene Homami; Farideh Ghazi
Journal:  Med J Islam Repub Iran       Date:  2016-12-29

8.  The Real-World Lifetime Economic Burden of Urothelial Carcinoma by Stage at Diagnosis.

Authors:  Abdalla Aly; Courtney Johnson; Yunes Doleh; Viktor Chirikov; Marc Botteman; Rahul Shenolikar; Arif Hussain
Journal:  J Clin Pathw       Date:  2020-05

Review 9.  Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease.

Authors:  Brian Dietrich; Sandy Srinivas
Journal:  Res Rep Urol       Date:  2018-01-26

10.  Music's effect on pain relief during outpatient urological procedures: a single center, randomized control trial focusing on gender differences.

Authors:  Christopher Anglin; Paul Knoll; Brandon Mudd; Craig Ziegler; Kellen Choi
Journal:  Transl Androl Urol       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.